During Friday's "Lightning Round" segment of Mad Money, one caller quizzed Jim Cramer about NantKwest (NK) . "I'm going to say yes to this speculative company. I'm fine with it," said Cramer about this a clinical-stage immunotherapy company.



During Friday's "Lightning Round" segment of Mad Money, one caller quizzed Jim Cramer about NantKwest (NK) . "I'm going to say yes to this speculative company. I'm fine with it," said Cramer about this a clinical-stage immunotherapy company.
When you put them together, trading success is nearly inevitable.
You can't call this market overbought when so much of it isn't participating.
What would I do in this case? Here's the logical choice.
SKLZ shows explosion moves to the upside when it emerges from the oversold area.
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login